Lyndsey Brawn

Lyndsey Brawn is a highly experienced professional in pharmacovigilance, currently serving as Senior Director of Pharmacovigilance (Safety Writing and Literature Surveillance Services) at Thermo Fisher Scientific since July 2025. Prior to this role, Lyndsey held various positions at PPD from February 2012 to June 2025, including Director and Associate Director of Pharmacovigilance, where responsibilities encompassed overseeing global safety writing services, managing remote teams, and preparing regulatory documents. Previous experience includes roles at Verius Ltd and a postdoctoral position at the University of Cambridge, where research focused on Salmonella proteins. Lyndsey holds a Doctor of Philosophy in Cellular Microbiology from the University of Cambridge and a Bachelor of Science with Honors in Pathology and Microbiology from the University of Bristol.